Ads
related to: hemophilia a- Pediatric Dosing & Admin
Dosing & Administration Resources
For Hemophilia A Patients Under 12.
- Dosing And Administration
Information For HCPs On Dosing,
Reconstitution and Administration.
- Perioperative Safety
Learn About Phase 3 Pivotal
Trial Results Showing Efficacy.
- Dosing & Administration
Information on Dosing,
Reconstitution and Administration.
- Efficacy Information
Phase 3 Pivotal Trial Results
Showing the Efficacy of Esperoct®.
- Pharmacology Information
Find More Information About
a Treatment Option.
- Pediatric Dosing & Admin
Search results
Novo Nordisk's (NVO) Haemophilia A Study Meets Safety Endpoint
Zacks via Yahoo Finance· 2 years agoNovo Nordisk's (NVO) phase I & II FRONTIER1 dose-escalation study investigating Mim8 for treating...
Roche's (RHHBY) Hemophilia A Drug Gets Positive CHMP Opinion
Zacks via Yahoo Finance· 1 year agoRoche RHHBY announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products...
Baudax's (BXRX) Hemophilia A Drug Gets FDA's Orphan Drug Tag
Zacks via Yahoo Finance· 8 months agoBaudax Bio BXRX announced that the FDA has granted the Orphan Drug designation to its...
Sanofi (SNY) Hemophilia A Drug BLA Gets FDA Priority Tag
Zacks via Yahoo Finance· 2 years agoSanofi SNY announced that the FDA has granted priority review to its biologics license application...
BioMarin (BMRN) Gets FDA Nod for Hemophilia A Gene Therapy
Zacks via Yahoo Finance· 11 months agoBioMarin BMRN announced that the FDA has approved Roctavian (valoctocogene roxaparvovec or valrox),...
Charles River (CRL) to Create New Gene Therapy for Hemophilia A
Zacks via Yahoo Finance· 2 years agoCharles River Laboratories International, Inc. CRL recently inked an agreement with ASC...
US FDA approves BioMarin's gene therapy for hemophilia A
Reuters via Yahoo News· 11 months ago(Reuters) -The U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical's gene...
FDA Approves Sanofi's Hemophilia A Therapy Offering Significant Bleed Protection
Benzinga via Yahoo Finance· 1 year agoThe FDA approved Sanofi SA's (NASDAQ: SNY) Altuviiio, previously referred to as efanesoctocog alfa,...
BioMarin (BMRN) Gets CHMP Nod for Hemophilia Drug Roctavian
Zacks via Yahoo Finance· 2 years agoBioMarin (BMRN) receives a positive CHMP opinion for Roctavian, its gene therapy for treating adults...
BioMarin Pharmaceutical: Pioneering Innovations Are Driving Future Growth
GuruFocus.com via Yahoo Finance· 3 months agoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a fast-growing pharmaceutical company focused on the...
Ads
related to: hemophilia a